Gold nanorods target cancer cells

Gold nanorods target cancer cells
Laser confocal scattering image of a HeLa cells cultured with EGF-Nanospheres for 30 mins (in green) together with a lipophilic tracer (DiD, in red).

Using tiny gold nanorods, researchers at Swinburne University of Technology have demonstrated a potential breakthrough in cancer therapy.

They have shown for the first time that gold nanorods can be used to inhibit in .

Dr Chiara Paviolo from Swinburne's Centre for Micro-Photonics attached tiny particles to the in HeLa cells from the first human cell line to be cloned to stop cancer cell proliferation.

"Cell receptors send growth signals to the cell by binding with an external molecule called a and then clustering together," Dr Paviolo said.

Growth factors are normally used to stimulate the growth of cells and are involved in 20 per cent of cancers.

"By placing growth factors at the ends of 100nm gold nanorods we could prevent the clustering of the receptors at a defined distance and thereby shut off the growth signal," she said.

"The simple explanation is that receptors need to cluster together to send a signal but if you keep them apart, it stops them from signalling."

Dr Paviolo said more research into the use of nanoparticles as blocking agents should be undertaken.

This work was undertaken by Dr Paviolo under the direction of Associate Professor Andrew Clayton and Associate Professor James Chon. It combines expertise in receptor biophysics and nanotechnology and highlights the multidisciplinary nature of the activities of the Centre for Micro-Photonics.

The research was funded by an ARC Discovery Grant and has been published in the prestigious nanotechnology journal Small.

Explore further

Arming nanoparticles for cancer diagnosis and treatment

More information: Paviolo, C., Chon, J. W. M. and Clayton, A. H. A. (2014), "Inhibiting EGFR Clustering and Cell Proliferation with Gold Nanoparticles." Small. doi: 10.1002/smll.201402701
Journal information: Small

Citation: Gold nanorods target cancer cells (2014, December 18) retrieved 24 September 2020 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments